non t-cell depleted haploidentical vs. matched sibling donor hsct in adult all in remission
Published 3 years ago • 68 plays • Length 2:39Download video MP4
Download video MP3
Similar videos
-
1:50
the benefits of haploidentical versus matched sibling donor hsct for patients with r/r all
-
7:04
hsct in aml: matched siblings versus haploidentical donors
-
2:34
comparing transplantation outcomes: haploidentical vs. unrelated donors
-
3:10
the efficacy of haploidentical transplantation in aml and all
-
3:38
t-cell-replete haploidentical stem cell transplantation in all
-
2:26
abtcd haploidentical hsct in pediatric al: long-term outcomes
-
0:42
haploidentical transplant in argentina
-
5:51
science talk with dr. jay l. wile, episode 06 | radioactive dating
-
1:20:01
t-cell depleted haploidentical stem cell transplantation in adults
-
13:27
factors in organ transplant rejection
-
1:09
assessing cardiovascular tolerability of zanubrutinib vs ibrutinib in pts with b-cell malignancies
-
2:05:23
is αβ t-cell/cd19 b-cell depletion the best platform for haploidentical hsct?
-
4:36
aml haplo-hsct outcomes
-
0:50
update on the pimms trial of ivosidenib for patients with idh1-mutated ccus
-
3:46
the impact of cytogenetic risk on outcomes of haploidentical transplantation in r/r aml
-
1:16
αβ t-cell depleted allo-hsct for hematological malignancies
-
2:13
haploidentical sct for the treatment of secondary aml
-
1:42
t-cell depleted haploidentical sct followed by atir101 vs. t-cell replete hsct plus chemo
-
1:53
canova trial: vendex versus pomdex in patients with r/r multiple myeloma
-
1:13
outcomes following fd & nfd related donor haplo transplantation for patients with acute leukemias
-
3:39
hsct with t-cell add-back of rivogenlecleucel in acute leukemia
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma